SPECIAL EMPHASIS PANELS
To view other meetings from ZAG1 choose calendar year:
Study Section | Panel Name | Meeting Rosters |
---|---|---|
ZAG1 ZIJ-2(M1) | NHP REVIEW | 05/07/25 |
ZAG1 ZIJ-1(C2) | MICROPHYSIOLOGICAL SYSTEMS FOR AD/ADRD THERAPY DEVELOPMENT | 05/06/25 |
ZAG1 ZIJ-8(M1) | TRAFFIC-RELATED AIR POLLUTION AND ULTRAFINE PARTICULATE MATTER IN ADRD RISK | 05/05/25 |
ZAG1 ZIJ-J(C1) | DIGITAL TECHNOLOGIES AS TOOLS TO SCREEN AND MONITOR ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) | 05/02/25 |
ZAG1 ZIJ-D(M1) | AD CLINICAL DRUG TRIALS | 05/02/25 |
ZAG1 ZIJ-3(M1) | STRESSORS AND AGING | 05/01/25 |
ZAG1 ZIJ-1(C1) | THERAPEUTIC CNS GENE DELIVERY | 04/28/25 |
ZAG1 ZIJ-5(C1) | AI/ML TOOLS FOR BEHAVIORAL AND SOCIAL SCIENCE RESEARCH | 04/24/25 |
ZAG1 ZIJ-D(M2) | BLOOD PRESSURE AND AD | 04/24/25 |
ZAG1 ZIJ-G(C1) | CONTRACTS REVIEW | 04/23/25 |
ZAG1 ZIJ-S(M2) | IMPACT OF SEX DIFFERENCES ON THE AD RISK | 04/23/25 |
ZAG1 ZIJ-5(M1) | PSYCHEDELIC-ASSISTED THERAPY FOR CHRONIC PAIN | 04/22/25 |
ZAG1 ZIJ-G(M2) | CLINICAL TRIALS FOR AGING CONDITIONS. | 04/18/25 |
ZAG1 ZIJ-I(M2) | REDI-R25 REVIEW MEETING | 04/18/25 |
ZAG1 ZIJ-J(M1) | ALZHEIMER'S DISEASE DRUG DEVELOPMENT PROGRAM | 04/18/25 |
ZAG1 ZIJ-5(M2) | NIA SBIR BIOBEHAVIORAL AND SOCIAL PROCESSES | 04/15/25 |
ZAG1 ZIJ-2(M2) | DEVELOPING STUDY ON AD/ADRD | 04/15/25 |
ZAG1 ZIJ-G(M1) | CLINICAL TRIALS FOR THE MANAGEMENT OF EARLY- AND LATE-AD | 04/11/25 |
ZAG1 ZIJ-R(O1) | 04/10/25 | |
ZAG1 ZIJ-T(M3) | NIA SBIR/STTR SPECIAL EMPHASIS PANEL | 04/08/25 |
ZAG1 ZIJ-P(M1) | ALTERED CELL SUBTYPES IN AGING AND AD/ADRD | 04/08/25 |
ZAG1 ZIJ-6(M2) | SBIR | 04/07/25 |
ZAG1 ZIJ-S(M3) | NIA IMPACT COLLABORATORY | 04/03/25 |
ZAG1 ZIJ-4(M1) | 03/25/25 | |
ZAG1 ZIJ-C(M1) | TRANSITION TO AGING RESEARCH FOR PREDOCTORAL STUDENTS | 03/12/25 |
ZAG1 ZIJ-F(M2) | RESEARCH INFRASTRUCTURE DEVELOPMENT FOR INTERDISCIPLINARY AGING STUDIES | 03/06/25 |
ZAG1 ZIJ-A(M1) | PATHOGENESIS AND TREATMENT OF ALZHEIMER'S DISEASE (AD) | 03/05/25 |
ZAG1 ZIJ-R(M2) | SWAN | 02/28/25 |
ZAG1 ZIJ-6(M1) | BEESON APPLICATIONS REVIEW | 02/25/25 |
ZAG1 ZIJ-3(C4) | MICROPHYSIOLOGICAL AGING SYSTEMS | 02/24/25 |
ZAG1 ZIJ-T(M2) | AGING RESEARCH | 02/21/25 |
ZAG1 ZIJ-R(M1) | INEQUITIES IN DIGITAL HEALTH FOR OLDER ADULTS WITH COGNITIVE DECLINE AND ADRD | 02/21/25 |
ZAG1 ZIJ-A(M3) | MECHANISMS OF THE AGE-RELATED CHANGES IN GAIT BIOMECHANICS AND THE IMPACT ON THE INCREASED METABOLIC COST OF WALKING | 02/20/25 |
ZAG1 ZIJ-F(M3) | FACTORS INFLUENCING COGNITIVE IMPAIRMENT | 02/20/25 |
ZAG1 ZIJ-9(M2) | RETROMER FUNCTION AND ALZHEIMERS DISEASE | 02/19/25 |
ZAG1 ZIJ-I(M1) | R03 MEDICAL TRANSITION TO AGING RESEARCH | 02/18/25 |
ZAG1 ZIJ-S(M1) | PEPPER CENTERS REVIEW | 02/18/25 |
ZAG1 ZIJ-F(M1) | AD AND ADRD RESEARCH IN LMIC'S | 02/14/25 |
ZAG1 ZIJ-T(M1) | BIOMARKERS FOR AD & ADRD | 02/13/25 |
ZAG1 ZIJ-9(M1) | AGING AND SPINAL CORD INJURY | 02/12/25 |
ZAG1 ZIJ-8(M2) | DOMINANTLY INHERITED ALZHEIMER NETWORK | 02/10/25 |
ZAG1 ZIJ-4(M2) | SHORT COURSES | 02/07/25 |
ZAG1 ZIJ-P(M3) | FRONTOTEMPORAL LOBAR DEGENERATION | 02/07/25 |
ZAG1 ZIJ-I(M3) | ALPHA HERPES VIRUSES AND ALZHEIMER'S DISEASE | 02/05/25 |
ZAG1 ZIJ-A(M2) | ROLE OF TAU IN NON-NEURONAL DYSFUNCTION IN ALZHEIMER'S DISEASE (AD) AND RELATED DISORDERS (RD) | 02/05/25 |
ZAG1 ZIJ-3(M2) | MATERNAL NUTRITION AND AGING | 02/04/25 |
ZAG1 ZIJ-P(M2) | BONE REGULATION | 01/10/25 |